相关实验视频

Updated: Mar 18, 2026

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

案例报告:针对突发性iMCD-TAFRO的TTP类表型的内皮向桥梁治疗

Jing Du¹, Liangliang Wu¹, Haigang Li²

¹Department of Emergency Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Frontiers in immunology

|March 16, 2026

概括

异常多中心卡斯特曼病-TAFRO可以呈现为一种严重的内皮损伤综合征,模仿年轻成年人的TTP. 以支持性护理和有针对性的IL-6阻断进行早期干预对于管理这种罕见的疾病至关重要.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
病理学病理学病理学

背景情况:

异常多中心卡斯特曼病-TAFRO (iMCD-TAFRO) 是一种罕见的亚型,具有特定的临床和病理特征.
诊断是具有挑战性的,因为重叠的症状与其他关键条件,如败血症和血栓微血管病变 (TMA).
内皮损伤是与iMCD-TAFRO相关的严重并发症的一个关键因素.

研究的目的:

描述一个IMCD-TAFRO呈现为 fulminant,TTP类综合征的年轻成年人的病例.
突出诊断方面的挑战以及区分iMCD-TAFRO与初级TTP的重要性.
为了说明一个管理策略,包括支持性护理,血交换和向治疗.

主要方法:

一个20岁的女性病例呈现出快速发烧,,黄和呼吸衰竭的情况.
实验室调查包括血小板计数,溶血性贫血标志物,IL-6水平和ADAMTS13活性.
淋巴结核活检用于对Castleman病的组织病理学确认.

主要成果:

该患者出现了严重的血小板缺血,微血管病变性血液溶解性贫血,升高的IL-6和严重低的ADAMTS13活性,模仿TTP.
通过淋巴结活检证实了iMCD-TAFRO的诊断.
治疗性血交换 (TPE) 和支持性护理的初始治疗稳定了患者,随后Siltuximab (抗IL-6疗法) 显著改善.

结论:

在年轻的成年人中,iMCD-TAFRO可以表现为严重的内皮病,与初级TTP非常相似.
在这种情况下,ADAMTS13活性降低可能是由于内皮细胞的激活和消耗,而不是自身免疫过程.
以病理生理学为基础的方法,结合支持措施和针对性治疗,如西尔图西马布,对于严重的iMCD-TAFRO是有效的.

关键词:

类似TTP的血栓性微血管病变.案例报告案例报告脑内皮质变异症 (Endotheliopathy) 是一种内皮质变异症.在 iMCD−TAFRO 中.异常多中心的卡斯特曼病异常多中心的卡斯特曼病.它可以抑制interleukin-6的抑制.治疗性血交换治疗性血交换血栓性微血管病变 - - 血栓性微血管病变

更多相关视频

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

相关概念视频

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...